Literature DB >> 12751963

Additive effects of radiation and docetaxel on murine SCCVII tumors in vivo: special reference to changes in the cell cycle.

Minoru Suzuki1, Kiyoshi Nakamatsu, Shuichi Kanamori, Shin-Ichiro Masunaga, Yasumasa Nishimura.   

Abstract

The purpose of the present study was to investigate the effects of a combination of docetaxel and irradiation in vivo with special reference to docetaxel-arrested G(2)/M-phase cells. At 24 and 48 h after intraperitoneal administration of docetaxel (90 mg/kg), tumor-bearing mice were irradiated with (60)Co gamma rays. Cell cycle distribution was analyzed by a DNA-Ki-67 double staining method using flow cytometry. An accumulation of cells in the G(2)/M phase of up to approximately 40% was observed 24 h after administration of docetaxel. Between 24 and 72 h, the percentage of cells arrested in G(2)/M phase that expressed Ki-67 decreased from 37.2% to 13.8%, in accordance with the increase in the Ki-67-negative G(2)/M-phase fraction. More than half of the cells arrested in G(2)/M phase lost their expression of Ki-67 protein between 24 and 72 h. The G(1)-phase fraction decreased from 28.4% to 8.6% at 24 h after docetaxel treatment; this remained unchanged at 72 h. These flow cytometry data suggested that docetaxel-arrested G(2)/M-phase cells did not enter the next cell cycle and were killed by docetaxel alone. Our data showed that arrest of cells in G(2)/M phase does not contribute to the synergism that has been reported for combinations of docetaxel and radiation in in vivo tumor models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751963     DOI: 10.1667/0033-7587(2003)159[0799:aeorad]2.0.co;2

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

Review 1.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

2.  Timing of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors.

Authors:  Shoji Kaku; Norichika Ushioda; Hiroshi Ishii; Takashi Murakami; Kentaro Takahashi; Yuichiro Nakai; Koichiro Shimoya; Takafumi Nakamura
Journal:  Oncol Rep       Date:  2014-05-20       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.